Skip to main content
. 2018 Jan 20;45(3):355–364. doi: 10.1007/s10928-018-9571-3

Fig. 4.

Fig. 4

Predicted difference in low-density-lipoprotein cholesterol (LDL-C) from coadministration for ezetimibe/atorvastatin fixed-dose combination (FDC) tablets as a function of atorvastatin geometric mean ratio (GMR). Median prediction: solid line; 95% confidence interval: shaded region; GMR of the observed bioequivalence (BE) data and 90% confidence interval: boxes with lines.

Reproduced with permission from Vargo et al. [17]